Breast cancer mortality among Ashkenazi Jewish women in Sao Paulo and Porto Alegre, Brazil

被引:6
作者
Koifman, S [1 ]
Koifman, RJ [1 ]
机构
[1] Minist Hlth, Oswaldo Cruz Fdn, Dept Epidemiol, Natl Sch Publ Hlth, Rio De Janeiro, Brazil
来源
BREAST CANCER RESEARCH | 2001年 / 3卷 / 04期
关键词
Ashkenazi; BRCA1; BRCA2; breast; cancer; mortality;
D O I
10.1186/bcr305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Increased BRCA1 and BRCA2 germline mutation rates have been reported in Ashkenazi Jewish women in North America, Europe and Israel, and have been mentioned as possibly related to a higher incidence of breast and ovarian cancer among these communities. The present study was carried out with the aim of obtaining evidence on the magnitude of breast cancer as a cause of death among Ashkenazi women in Brazil. Methods: We reviewed all death certificates archived in the Jewish Burial Societies of Sao Paulo (1971-1997) and Porto Alegre (1948-1997), two of the main and oldest Jewish communities in Brazil. Breast cancer observed deaths were compared with expected deaths according to breast cancer mortality in the general population. Results: The observed ratios were approximately quite close to unity, suggesting a similar breast cancer mortality pattern among the Ashkenazi population and the general population in both cities. These results maintain similar behavior regardless of whether analyzed before or after the mid-1980s, when mammography came to be increasingly performed in Brazil. Cancer proportional mortality ratios were 1.04 (0.83-1.29) in Sao Paulo and 1.16 (0.84-1.57) in Porto Alegre before 1985, and 1.17 (1.00-1.44) and 1.21 (0.81-1.79), respectively, between 1985 and 1997. Some evidence of the maintenance of protective risk factors such as high parity has been observed among Ashkenazi women in Sao Paulo. Conclusion: A quite similar breast cancer mortality pattern was observed between Ashkenazi Jewish women and the general population in Sao Paulo and Porto Alegre, Brazil. These results may suggest an environmental role on germ mutation expression reported in this ethnic group.
引用
收藏
页码:270 / 275
页数:6
相关论文
共 23 条
[1]  
BRUMER A, 1994, IDENTIDADE MUDANCA P, P61
[2]   PATTERNS OF AMERICAN JEWISH FERTILITY [J].
DELLAPERGOLA, S .
DEMOGRAPHY, 1980, 17 (03) :261-273
[3]   Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer [J].
FitzGerald, MG ;
MacDonald, DJ ;
Krainer, M ;
Hoover, I ;
ONeil, E ;
Unsal, H ;
SilvaArrieto, S ;
Finkelstein, DM ;
BeerRomero, P ;
Englert, C ;
Sgroi, DC ;
Smith, BL ;
Younger, JW ;
Garber, JE ;
Duda, RB ;
Mayzel, KA ;
Isselbacher, KJ ;
Friend, SH ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :143-149
[4]   Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients [J].
Fodor, FH ;
Weston, A ;
Bleiweiss, IJ ;
McCurdy, LD ;
Walsh, MM ;
Tartter, PI ;
Brower, ST ;
Eng, CM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (01) :45-51
[5]   Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumors [J].
Gotlieb, WH ;
Freidman, E ;
Bar-Sade, RB ;
Kruglikova, A ;
Hirsh-Yechezkel, G ;
Modan, B ;
Inbar, M ;
Davidson, B ;
Kopolovic, J ;
Novikov, I ;
Ben-Baruch, G .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (13) :995-1000
[6]   BRCA1 germline mutations in women with uterine serous papillary carcinoma [J].
Lavie, O ;
Hornreich, G ;
Ben Arie, A ;
Renbaum, P ;
Levy-Lahad, E ;
Beller, U .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (01) :28-32
[7]  
LevyLahad E, 1997, AM J HUM GENET, V60, P1059
[8]   A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer [J].
Lu, KH ;
Cramer, DW ;
Muto, MG ;
Li, EY ;
Niloff, J ;
Mok, SC .
OBSTETRICS AND GYNECOLOGY, 1999, 93 (01) :34-37
[9]  
*MIN SAUD, 1980, EST MORT
[10]  
*MIN SAUD, 1994, EST MORT